Psychotherapy and Psychosomatics , 84(5), 254258
spending surged to approximately $71.7 billion in 2023, up from $13.7 billion in 2018 for a nearly 500% increase
Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
Premier Protein and Orgain have also been focusing on high-protein, low-calorie drinks, appealing to consumers who need small but high-quality sources of protein, which can be more challenging for GLP-1 users with reduced appetite